NEMESIS to Present Cutting-edge Biosignal Processing Technologies at LSI Europe ’24

Sintra, Portugal – [9/18/2024] – NEMESIS, a leading South Korean biosignal processing semiconductor solutions provider for small-size diagnostic digital healthcare applications, is thrilled to announce its participation in the prestigious LSI Europe ’24 event. The event attracts over 1,000 Medtech leaders including innovators, strategics, and investors. The presentation will be held at the Main Hotel in Sintra on September 18, 2024.

Dr. Wang, Co-founder and CEO of NEMESIS, will present the company’s innovative and highly precise biosignal processing technologies. His presentation is scheduled from 2:40 PM to 2:49 PM. Dr. Wang’s vision for becoming the top silicon partner for digital healthcare device manufacturers will also be a key highlight of the session.

NEMESIS boasts proprietary technologies in advanced analog biosignal processing chip design, featuring a wide dynamic range, high input impedance, and a multi-modal sensing interface capable of handling various markers such as EEG, ECG, EMG, Bio-Z, and electrochemical signals. Additionally, the company utilizes cutting-edge Tiny Machine Learning for digital signal processing and System-on-Chip (SoC) design.

“We provide customized solutions for each innovative device, unlike other companies who only offer ready-made chips, making optimization challenging.” Dr. Wang stated. “NEMESIS delivers a comprehensive package that includes System on Chip (SoC), algorithms, and services, whereas other companies typically provide only the SoC. Our incorporation of AI algorithms based on Tiny Machine Learning, our unique universal interface technology, and flexible technical support specifically designed to accommodate biosensor input set us apart from others in the industry. Furthermore, NEMESIS offers all-inclusive solutions with integrated Bluetooth, unlike other providers who offer separate packages.”

NEMESIS invites all innovators attending LSI Europe ’24 to join Dr. Wang’s presentation to learn more about the company’s state-of-the-art technology and solutions. Interested innovators and strategic partners are encouraged to contact NEMESIS directly at sophie.lee@nemesis.kr to schedule private meetings and discuss potential collaborations.

For more information, please visit https://vitalic.tech or nemesis.blog for English.

Media Contact:

Sophie Lee
NEMESIS
Email: sophie.lee@nemesis.kr